Aberrant MUC Immunohistochemical Expressions in Inflammatory Bowel Diseases

被引：2

作者：

Hamamoto, Yuichiro ^{[1
,3
,5
]}

Kawamura, Michihiro ^{[2
]}

Uchida, Hiroki ^{[2
]}

Takagahara, Kojiro ^{[2
]}

Katori, Chiaki ^{[2
]}

Asai, Hinako ^{[2
]}

Harada, Hiroshi ^{[1
]}

Shimizu, Shigeki ^{[4
]}

Morii, Eiichi ^{[3
]}

Yoshida, Kyotaro ^{[1
,2
]}

机构：

[1] Kinki Cent Hosp, Dept Diagnost Pathol, Itami, Hyogo, Japan

[2] Kinki Cent Hosp, Dept Clin Lab, Itami, Hyogo, Japan

[3] Osaka Univ, Dept Pathol, Grad Sch Med, Suita, Japan

[4] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Clin Lab, Kita Ku, Osaka, Japan

[5] Kinki Cent Hosp, Dept Diagnost Pathol, 3-1 Kurumaduka,, Itami, Hyogo 6648533, Japan

来源：

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | 2023年 / 31卷 / 02期

关键词：

mucin; MUC; ulcerative colitis; crohn disease; ischemic colitis; inflammatory bowel disease; immunohistochemistry; ULCERATIVE-COLITIS; BARRIER;

D O I：

10.1097/PAI.0000000000001096

中图分类号：

R602 [外科病理学、解剖学]; R32 [人体形态学];

学科分类号：

100101 ;

摘要：

Ulcerative colitis (UC) and Crohn disease (CD) are cryptogenic inflammatory bowel diseases that are suggestive of aberrant mucin (MUC) expression; however, their relationship remains unclear. Here, we examined aberrant MUC expression in intestinal samples from UC and CD patients in comparison to samples from patients with ischemic colitis and control groups. To study the expression of MUC1, MUC5AC, and MUC6 in different patient groups, we reviewed the slides stained with hematoxylin and eosin and performed immunohistochemistry. The results revealed that MUC1 was expressed more in the UC group and MUC6 in the CD group. No significant changes were observed in MUC expression in the ischemic colitis group. Overall, we demonstrated changes in MUC expression in UC and CD, which can help in the diagnosis and early clinical management of UC and CD.

引用

页码：107 / 112

页数：6

共 50 条

[1] Aberrant Expression of MUC1 Mucin in Pediatric Inflammatory Bowel Disease
Furr, Anna E.
Ranganathan, Sarangarajan
Finn, Olivera J.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2010, 13 (01) : 24 - 31
[2] Aberrant immunohistochemical expressions in gastric carcinomas
Scaueru, Nitu S.
Hedesan, O.
Scaueru, Nitu A.
Lazar, D.
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 156 - 156
[3] ABERRANT LYMPHOCYTE BINDING TO VASCULAR ENDOTHELIUM IN INFLAMMATORY BOWEL DISEASES
JALKANEN, S
GRANFORS, K
SALMI, M
JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 350 - 350
[4] Immunohistochemical study of adhesion molecules in irritable bowel syndrome: A comparison to inflammatory bowel diseases
Mitselou, Antigony
Grammeniatis, Vasileios
Varouktsi, Anna
Papadatos, Stamatis S.
Klaroudas, Antonios
Katsanos, Konstantinos
Galani, Vasiliki
ADVANCED BIOMEDICAL RESEARCH, 2021, 10 (01): : 21
[5] Neuropeptides and Nerve Growth in Inflammatory Bowel Diseases: A Quantitative Immunohistochemical Study
C.M.Y. Lee
R.K. Kumar
D.Z. Lubowski
E. Burcher
Digestive Diseases and Sciences, 2002, 47 : 495 - 502
[6] Neuropeptides and nerve growth in inflammatory bowel diseases - A quantitative immunohistochemical study
Lee, CMY
Kumar, RK
Lubowski, DZ
Burcher, E
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (03) : 495 - 502
[7] ABERRANT BINDING OF LAMINA PROPRIA LYMPHOCYTES TO VASCULAR ENDOTHELIUM IN INFLAMMATORY BOWEL DISEASES
SALMI, M
GRANFORS, K
MACDERMOTT, R
JALKANEN, S
GASTROENTEROLOGY, 1994, 106 (03) : 596 - 605
[8] Focal gastric inflammatory infiltrates in inflammatory bowel diseases: Prevalence, immunohistochemical characteristics, and diagnostic role
Parente, F
Cucino, C
Bollani, S
Imbesi, V
Maconi, G
Bonetto, S
Vago, L
Porro, GB
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (03): : 705 - 711
[9] Inflammatory bowel diseases
Schiessel, R
CHIRURGISCHE GASTROENTEROLOGIE, 1998, 14 (02): : 89 - 89
[10] INFLAMMATORY BOWEL DISEASES
ALONSO, GG
VECCHIONI, R
GENERAL SURGERY : CURRENT STATUS AND FUTURE TRENDS, 1989, 60 : 297 - 298

← 1 2 3 4 5 →